Document:

Exhibit 10.2

 

 

Invoice

 

	Attention:	James Foster/ Emmie Shi	Date:	26-Apr-21
	Company:	Shanghai Biotechnology Devices Limited	Invoice No.:	21040103VSCS
	E-mail:	jf@viraxclear.com; emmie@naturalsourcegroup.com	Client Code:	S04980
	Telephone:	 +86 155 0210 4023 / +86
1366 1816 791	 	 

 

	SCOPE OF SERVICES	 	PRICE
 HK$	 
	 	 	 	 
	SHANGHAI BIOTECHNOLOGY DEVICES LIMITED	 	 	 
	ANNUAL COMPANY SECRETARIAL SERVICE	 	 	 
	For the period from Appointment date – 13/04/2022	 	 	1,200	 
	Preparation of Annual return	 	 	 	 
	Preparation of forms to Companies Registry for changes of:-(2 times each)	 	 	 	 
	Director	 	 	 	 
	Registered Address	 	 	 	 
	Company Name	 	 	 	 
	 	 	 	 	 
	VIRTUAL OFFICE SERVICE (2104 MK)	 	 	 	 
	For the period from Appointment date – 13/04/2022	 	 	2,220	 
	Provide commercial address for company registration	 	 	 	 
	Receive mail with notification by email	 	 	 	 
	NameplateAppointment date – 13/04/2022	 	 	 	 
	 	 	 	 	 
	Designated Representative	 	 	 	 
	For the period from Appointment date – 13/04/2022	 	 	1,000	 
	Prepare Significant Controllers Register	 	 	 	 
	Keeping of Significant Controllers Register	 	 	 	 
	 	 	 	 	 
	TOTAL	 	 	4,420	 

 

		Remarks: 	1. Payment should be payable to “Flexkin Corporate Services Limited”.

			2.Regarding to the payment, any bank charge would be borne
by client.

 

		
    Beneficial name: Flexkin Corporate
    Services Limited

    Bank Name: Bank of China (Hong Kong) Limited

    Bank Address: 589 Nathan Road, Mongkok, Kowloon

    A/C no.: 012-586-00135542

    Swift Code: BKCHHKHH

    FPS ID no.: 7136468

    

 

Room
2104, Mongkok Commercial Centre, 16 Argyle Street, Mongkok, Kowloon, Hong Kong

九龍旺角亞皆老街16號旺角商業大廈2104室
Tel: (852) 3728 3000 Fax: (852) 3728 3001Exhibit 10.3

 

SHARE EXCHANGE AGREEMENT

 

This Share Exchange
Agreement (this Agreement) is made on 20th September 2021.

 

BETWEEN

 

	1	Virax Biolabs (Cayman) Limited, an exempted company incorporated under the laws of the Cayman Islands
with company number 380440 whose registered office is located at the office of Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay,
Grand Cayman, KY1-9009, Cayman Islands (the Cayman Holdco);

 

	2	Virax Biolabs (UK) Limited, a company incorporated under the laws of England and Wales with company number
13630639 whose registered office is located at 30 Broadwick Street, London, W1F 8JB, United Kingdom (the UK Company);

 

	3	Virax Biolabs Limited, a limited company organized under the laws of Hong Kong with company number 29311747
whose registered office is located at Unit 2104, Mongkok Commercial Centre, 16 Argyle Street, Mongkok, Kowloon, Hong Kong (the HK Company);
and

 

	4	Each of the selling shareholders of the HK Company as listed in Schedule 1 hereto (each a Selling Shareholder,
and collectively, the Selling Shareholders).

 

Each of the parties
to this Agreement is individually referred to herein as a party and collectively as the parties.

 

RECITALS

 

	A.	The Cayman Holdco is a holding company incorporated under the laws of the Cayman Islands with an authorised
share capital of US$50,000 divided into 492,000,000 class A ordinary shares of US$0.0001 par value each (the Class A Shares) and
(ii) 8,000,000 class B ordinary shares of US$0.0001 par value each (the Class B Shares), of which 1 Class B Share is currently
issued and outstanding. The rights of the Class A Shares and Class B Shares are set out in the memorandum and articles of association
of the Cayman Holdco, a copy of which is attached as Schedule 2 hereto.

 

	B.	The Cayman Holdco holds 100% of the issued share capital of the UK Company.

 

	C.	As at the date of this Agreement, the HK Company has 102,478,548 ordinary shares issued and outstanding,
all of which are collectively held by the Selling Shareholders (the HK Shares). The Selling Shareholders have agreed to transfer
the HK Shares to the UK Company, being a wholly owned subsidiary of the Cayman Holdco, in exchange for an aggregate of (i) 2,549,028 newly
issued Class A Shares and (ii) 7,034,305 newly issued Class B Shares of the Cayman Holdco (collectively, the Cayman Shares).

 

	D.	The board of directors of each of the Cayman Holdco, the UK Company and the HK Company has determined
that it is desirable to effect this plan of reorganization and share exchange.

 

    1

     

    

 

NOW THEREFORE,
in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth herein, and intending
to be legally bound hereby, the Parties agree as follows:

 

	1	Interpretation

 

	1.1	In this Agreement:

 

Business Day
means any day, not being a Saturday, Sunday or public holiday, when the banks of Cayman Islands and Hong Kong are open for business; 

 

Cayman
Shares has the meaning given in the Recitals;

 

Class A Shares
has the meaning given in the Recitals;

 

Class B Shares
has the meaning given in the Recitals;

 

Completion
means completion of the transfer and issue of the shares pursuant to this Agreement;

 

Completion
Date means the date of this Agreement;

 

Encumbrance
means any and all charges, liens, equities, encumbrances, claims or restrictions;

 

Governmental
Entity means any government or any court of competent jurisdiction, administrative agency or commission or other governmental authority
or instrumentality, domestic or foreign;

 

HK Shares has
the meaning prescribed in the Recitals;

 

Laws means
statutes, laws, ordinances, rules, regulations, orders, writs, injunctions, judgments, decrees, common law, or any rule, regulation, directive,
treaty provision, governmental guidelines or interpretations having the force of law, permits and orders of any Governmental Entity.

 

Parent company
means any company which holds a majority of the voting rights in another company, or which is a member of another company and has the
right to appoint or remove a majority of its board of directors, in either case whether directly or indirectly through one or more companies;
and

 

Subsidiaries
means any company in relation to which the another company is its Parent Company.

 

    2

     

    

 

	1.2	In this Agreement, unless the context otherwise requires:

 

		(a)	references to this Agreement or any other document include this Agreement or such other document as varied,
modified or supplemented in any manner from time to time;

 

		(b)	references to any party shall, where relevant, be deemed to be references to or to include, as appropriate,
their respective permitted successors, assigns or transferees;

 

		(c)	references to Recitals and Clauses and sub-divisions of them are references to the Recitals and Clauses
of this Agreement and sub-divisions of them respectively;

 

		(d)	references to any enactment include references to such enactment as re-enacted, amended or extended and
any subordinate legislation made from time to time under it;

 

		(e)	references to a person include any individual, company, corporation, firm, partnership, joint venture,
association, organisation, institution, trust or agency, whether or not having a separate legal personality;

 

		(f)	a word which denotes the singular also denotes the plural, a word which denotes the plural also denotes
the singular, and a reference to any gender also denotes the other genders;

 

		(g)	any reference to indemnifying any person against any circumstance includes indemnifying and holding that
person harmless from all actions, claims, demands and proceedings of any nature from time to time made against that person and all losses,
damages, payments, awards, costs or expenses made, suffered or incurred by that person as a consequence of, or which would not have arisen
but for, that circumstance;

 

		(h)	references to US$ are references to the currency of the United States of America; and

 

		(i)	headings are inserted for convenience only and shall be ignored in construing this Agreement.

 

	1.3	The Recitals and Schedule to this Agreement form part of
this Agreement.

 

	2	Exchange of Shares

 

	2.1	On and subject to the terms of this Agreement, each of the
Selling Shareholders shall transfer with full title guarantee the HK Shares that he holds as set forth in Schedule 1 to the UK
Company on and with effect from Completion, in each case free from all Encumbrances whatsoever and together with all rights which are
now, or at any time hereafter may become, attached to them (including without limitation the right to receive all dividends and distributions
declared, made or paid on or after the Completion Date).

 

	2.2	In consideration for the transfer of the HK Shares, the Cayman
Holdco shall issue the Cayman Shares, credited as fully paid, to the Selling Shareholders in accordance with Schedule 1. Each
Selling Shareholder agrees and consents to the entry of his/her/its registered address as recorded in the register of members of the
HK Company as his/her/its address to be recorded in the register of members of the Cayman Holdco.

 

    3

     

    

 

	2.3	The Cayman Holdco shall not be obliged to issue the Cayman
Shares unless the transfer of all the HK Shares to the UK Company is completed simultaneously and if such transfer is not completed on
the Completion Date then the Cayman Holdco shall be entitled to rescind this Agreement without liability of any kind on its part, but
without prejudice to its rights in respect of any pre-existing breach of the terms hereof, including any breach giving rise to such right
to rescind.

 

	3	Completion

 

	3.1	Subject to the provisions of this Clause, Completion shall take
place on the Completion Date.

 

	3.2	On Completion, each of the Selling Shareholders shall cause to be delivered to Cayman Holdco:

 

		(a)	a duly executed transfer instrument in respect of all the HK Shares that it holds in favour of the UK
Company, together with the share certificates relating to such shares;

 

		(b)	a duly executed bought and sold notes in respect of all of the HK Shares that it holds in favour of the
UK Company;

 

		(c)	share certificates (if any) in respect of all the HK Shares;

 

		(d)	(in respect of any Selling Shareholders which is a corporate entity) a copy of the resolution of its board
of directors authorising the execution of and the performance by the relevant company of its obligations under this Agreement;

 

		(e)	a duly signed copy of this Agreement; and

 

		(f)	such other documents (including any power of attorney under which any document required to be delivered
under this Clause has been executed and any waivers or consents) as the UK Company may require to enable it to be registered as the holder
of the HK Shares.

 

	3.3	On Completion, the HK Company shall:

 

		(a)	cause written resolutions of the directors of the HK Company duly passed at which the transfers of the
HK Shares shall be approved for registration;

 

		(b)	procure that a copy of this Agreement, duly executed and dated, to be delivered to Hong Kong Stamp Office
for stamping; and

 

		(c)	provide a copy of the updated register of members of the HK Company to the Cayman Holdco evidencing that
the UK Company is the sole shareholder of all of the issued shares of the HK Company.

 

    4

     

    

 

	3.4	On Completion, the Cayman Holdco shall, following compliance by the HK Company with the foregoing:

 

		(a)	cause written resolutions of the director of the Cayman Holdco duly passed at which the issuance and allotment
of the Cayman Shares shall be approved for registration;

 

		(b)	procure the issuance to each of the Selling Shareholders of the Cayman Shares; and

 

		(c)	deliver a share certificate in respect of the newly issued Cayman Shares to the Selling Shareholders.

 

	3.5	At any time on or after the Completion Date, each of the
Selling Shareholders shall take all reasonable steps to execute such documents, and take such further action, as the Cayman Holdco and/or
the UK Company may reasonably require for the purpose of giving effect to the provisions of this Agreement.

 

	4	Representations and Warranties of each Selling Shareholder

 

	4.1	Each Selling Shareholder hereby represent and warrant to the Cayman Holdco as of the date hereof as follows:

 

		(a)	Good Title. The Selling Shareholders are the legal and beneficial owners of, and have good title
to, the HK Shares, with the right and authority to sell and deliver the HK Shares to the UK Company as provided herein. Upon delivery
of any certificate or certificates duly endorsed for transfer to the UK Company representing the same as herein contemplated and/or upon
registering of the UK Company as the new owner of the HK Shares in the share register of the HK Company, the UK Company will receive good
title to the HK Shares, free and clear of Encumbrances.

 

		(b)	Power and Authority. All acts required to be taken by the Selling Shareholders to enter into this
Agreement and to carry out the transactions contemplated herein have been properly taken. This Agreement constitutes a legal, valid and
binding obligation of the Selling Shareholders, enforceable against the Selling Shareholders in accordance with the terms hereof.

 

		(c)	No Conflicts. The execution and delivery of this Agreement by the Selling Shareholders and the
performance by the Selling Shareholders of their obligations hereunder in accordance with the terms hereof: (i) will not require the consent
of any third party or any Governmental Entity under any Laws; (ii) will not violate any Laws applicable to the Selling Shareholders; and
(iii) will not violate or breach any contractual obligation to which the Selling Shareholders are a party.

 

	 	(d)	Purchase Entirely for Own Account. The Cayman Shares
proposed to be acquired by the Selling Shareholders hereunder will be acquired for investment for their own account, and not with a view
to the resale or distribution of any part thereof, and the Selling Shareholders have no present intention of selling or otherwise distributing
the Cayman Shares, except in compliance with applicable securities laws.

 

    5

     

    

 

		(e)	Available Information. The Selling Shareholders have such knowledge and experience in financial
and business matters that they are capable of evaluating the merits and risks of an investment in the Cayman Holdco.

 

	5	Representations and Warranties of the HK Company

 

The HK Company
hereby represent and warrant to the Cayman Holdco, as follows:

 

	5.1	Organization, Standing and Power. The HK Company and
each of its Subsidiaries is duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is organized
and in which it has a place of business and has the corporate power and authority and possesses all governmental franchises, licenses,
permits, authorizations and approvals necessary to enable it to own, lease or otherwise hold its properties and assets and to conduct
its businesses as presently conducted.

 

	5.2	Capital Structure. The HK Shares constitute the whole
of the issued share capital of the HK Company. No person has the right or option (exercisable now or in the future and whether contingent
or not) to call for the issue of any share or loan capital in the HK Company. All the HK Shares are duly authorized, validly issued,
fully paid or properly credited as fully paid and there is no liability to pay any additional contributions on the HK Shares. The HK
Shares are not subject to or issued in violation of any purchase option, call option, right of first refusal, pre-emptive right, subscription
right or any similar right under any provision of the applicable corporate laws of Hong Kong, the HK Company’s constitutional documents
or any agreement or contract to which the HK Company is a party or otherwise bound.

 

	5.3	Subsidiaries. The information in respect of the HK
Company’s group structure set out in Schedule 3 is true, accurate, complete and not misleading. The HK Company (or its Subsidiary)
is the sole legal and beneficial owner free from all Encumbrances of the issued shares in the capital of the relevant Subsidiary of which
is it identified as a shareholder. All such shares are fully paid or properly credited as fully paid and there is no outstanding liability
to pay any additional contributions on such shares. No person has the right (exercisable now or in the future and whether contingent
or not) to call for the issue of any shares or loan capital in any Subsidiary.

 

	5.4	Authority; Execution and Delivery; Enforceability.
The HK Company has all requisite corporate power and authority to execute and deliver this Agreement and to consummate the transactions
contemplated herein. The execution and delivery by the HK Company of this Agreement and the consummation by the HK Company of the transactions
contemplated herein have been duly authorized and approved by the board of directors of the HK Company and no other corporate proceedings
on the part of the HK Company are necessary to authorize this Agreement and the transactions contemplated herein. When executed and delivered,
this Agreement will be enforceable against the HK Company in accordance with its terms, subject to bankruptcy, insolvency and similar
laws of general applicability as to which the HK Company is subject.

  

    6

     

    

 

	5.5	Litigation.
                                            Neither the HK Company nor any of its Subsidiaries is a not a party to any litigation,
                                            arbitration or administrative proceedings which are in progress, threatened or pending by
                                            or against or concerning it or any of its assets.

 

	5.6	Compliance with Applicable Laws. Each of the HK Company
and its Subsidiaries is in compliance with all applicable Laws at all times.

 

	5.7	Contracts and Title to Properties. None of HK Company
or any of its Subsidiaries is in violation of or in default under (nor does there exist any condition which upon the passage of time
or the giving of notice would cause such a violation of or default under) any contract to which it is a party or by which it or any of
its properties or assets is bound. Each of the HK Company and its Subsidiaries has sufficient title to, or valid leasehold interests
in, all of its properties and assets (including, without limitation, any intellectual property rights and licences) used in the conduct
of its businesses.

 

	6	Representations and Warranties of the Cayman Holdco

 

The Cayman Holdco
hereby represent and warrant to each Selling Shareholder, as follows:

 

	6.1	Organization, Standing and Power. The Cayman Holdco is
duly incorporated, validly existing and in good standing under the laws of the Cayman Islands and has full corporate power and authority
and possesses all governmental franchises, licenses, permits, authorizations and approvals necessary to enable it to own, lease or otherwise
hold its properties and assets and to conduct its businesses as presently conducted.

 

	6.2	Capital Structure. The authorized share capital of the
Cayman Holdco is US$50,000 comprising of (i) 492,000,000 Class A Shares and (ii) 8,000,000 Class B Shares, of which 1 Class B Share has
been issued. No other shares or other voting securities of the Cayman Holdco are issued, reserved for issuance or outstanding. All outstanding
share(s) of the Cayman Holdco are duly authorized, validly issued, fully paid and non-assessable and not subject to or issued in violation
of any purchase option, call option, right of first refusal, pre-emptive right, subscription right or any similar right under any provision
of the laws and regulations of the Cayman Islands, the Cayman Holdco’s constitutional documents, or any agreement or contract to which
the Cayman Holdco is a party or otherwise bound.

 

	6.3	Authority; Execution and Delivery; Enforceability.
The Cayman Holdco has all requisite corporate power and authority to execute and deliver this Agreement and to consummate the transactions
contemplated herein. The execution and delivery by the Cayman Holdco of this Agreement and the consummation by the Cayman Holdco of the
transactions contemplated herein have been duly authorized and approved by the board of directors of the Cayman Holdco and no other corporate
proceedings on the part of the Cayman Holdco are necessary to authorize this Agreement and the transactions contemplated herein. When
executed and delivered, this Agreement will be enforceable against the Cayman Holdco in accordance with its terms, subject to bankruptcy,
insolvency and similar laws of general applicability as to which the Cayman Holdco is subject.

 

    7

     

    

 

	6.4	Litigation. The Cayman Holdco is a not a party to any
litigation, arbitration or administrative proceedings which are in progress, threatened or pending by or against or concerning it or
any of its assets.

 

	6.5	Compliance with Applicable Laws. The Cayman Holdco is in compliance with all applicable Laws.

 

	7	Costs

 

	7.1	Subject to Clause 7.2 and except as otherwise provided in this
Agreement, the HK Company shall be responsible for its own, Cayman Holdco and UK Company’s costs, charges and other expenses (including
those of its Affiliates) incurred in connection with negotiating, preparing, entering into and completing this Agreement and the other
Transaction Documents (including any notarisation and/or registration fees if applicable) and the Selling Shareholders shall each be
responsible for their own respective costs, charges and other expenses (including those of its Affiliates) incurred in connection with
negotiating, preparing, entering into and completing this Agreement and the other Transaction Documents (including any notarisation and/or
registration fees if applicable).

 

	7.2	Any stamp duty or other transfer taxes (including interest and
penalties) payable in respect of the transfer of the HK Shares shall be borne by the UK Company.

 

	8	Notices

 

	8.1	Any notice or other communication to be given under this Agreement
shall be in writing, shall be deemed to have been duly served on, given to or made in relation to a party if it is left at the authorised
address of that party, posted by pre-paid airmail/first class/registered post addressed to that party at such address, or sent by facsimile
transmission to a machine situated at such address and shall if:

 

		(a)	personally delivered, be deemed to have been received at the time of delivery;

 

		(b)	posted, be deemed to have been received on the fifth Business Day after the date of posting; or

 

		(c)	sent by facsimile transmission, be deemed to have been received upon receipt by the sender of a facsimile
transmission report (or other appropriate evidence) that the facsimile has been transmitted to the addressee,

 

provided
that where, in the case of delivery by hand or facsimile transmission, delivery or transmission occurs after 6.00 pm on a Business Day
or on a day which is not a Business Day, receipt shall be deemed to occur at 9.00 am on the next following Business Day.

 

    8

     

    

 

	8.2	For the purposes of this Clause the authorised address of (i)
the Cayman Holdco, the UK Company and the HK Company shall be the address set out at the heading of this Agreement and (ii) the Selling
Shareholders shall be the address as set out in the register of members of the HK Company as at the date of this Agreement, or such other
address as that party may notify to the others in writing from time to time in accordance with the requirements of this Clause

 

	9	Severance

 

	9.1	If any provision of this agreement is held to be illegal, invalid or unenforceable under the laws of any
jurisdiction:

 

		(a)	the legality, validity and enforceability of the remainder of this Agreement shall not be affected;

 

		(b)	the legality, validity and enforceability of the whole of this Agreement in any other jurisdiction shall
not be affected;

 

		(c)	such illegal, void or unenforceable provision shall be deemed to be severable from any other provision
of this Agreement; and

 

		(d)	the parties shall negotiate in good faith to agree the terms of a mutually acceptable and satisfactory
alternative provision in place of the provision so deleted.

 

	9.2	Without derogating from the preceding clause, the parties agree
to negotiate in good faith the terms of an alternative provision in the relevant jurisdiction in place of the deleted provision.

 

	10	Waiver

 

	10.1	A waiver of any right, power, or remedy under this agreement
must be in writing signed by the party granting it. It may be given subject to any conditions the grantor thinks fit. The fact that a
party fails to do, or delays in doing, something the party is entitled to do under this agreement does not amount to a waiver.

 

	10.2	A waiver is only effective in relation to the particular obligation
or breach in respect of which it is given. It is not to be taken as an implied waiver of any other obligation or breach or as an implied
waiver of that obligation or breach in relation to any other occasion.

 

	11	Entire agreement and variation

 

	11.1	This Agreement (together with any documents referred to herein)
contains the entire agreement and understanding of the parties and supersedes all prior agreements, understandings or arrangements (both
oral and written) relating to the subject matter of this Agreement.

 

	11.2	No variation, supplement, deletion or replacement of or from
this Agreement or any of its terms shall be effective unless made in writing and signed by or on behalf of each party.

 

    9

     

    

 

	12	Miscellaneous

 

	12.1	Each of the parties hereto shall execute and deliver all such
instruments and other documents and take all such actions as are reasonably required in order to give full effect to the provisions of
this Agreement.

 

	12.2	This Agreement may not be assigned by either party without the
written consent of the other.

 

	12.3	This Agreement may be executed in any number of counterparts,
all of which taken together constitute one and the same document.

 

	13	Third Party Rights

 

	13.1	A person who is not a party to this Agreement has no right under
the Contracts (Rights of Third Parties) Act, 2014, as amended, modified, re-enacted or replaced, to enforce directly any term of this
Agreement. Notwithstanding any other term of this Agreement, the consent of any person who is not a party to this Agreement is not required
for any variation of, amendment to, or release, rescission, or termination of, this Agreement

 

	14	Governing law and jurisdiction

 

	14.1	This Agreement is governed by the law of the Cayman Islands.

 

	14.2	The parties submit to the non-exclusive jurisdiction of the courts
of the Cayman Islands and the courts of appeal from them to determine any dispute arising out of or in connection with this agreement.
The parties agree not to object to the exercise of jurisdiction of those courts on any basis.

 

[Signature Page Follows]

 

    10

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed and delivered this Share Exchange Agreement as of the date first above written.

 

	CAYMAN HOLDCO:	 
	 	 	 
	For and on behalf of	 
	Virax Biolabs (Cayman) Limited	 
	 	 	 
	By:	/s/ Foster
    James Alexander Cunliffe	 
	Name:	Foster James Alexander
    Cunliffe	 
	Title:	Director	 
	 	 	 
	UK COMPANY: 	 
	 	 	 
	For and on behalf of	 
	Virax Biolabs (UK) Limited 	 
	 	 	 
	By:	/s/ James
    Foster	 
	Name:	James Foster	 
	Title:	Director	 
	 	 	 
	HK COMPANY: 	 
	 	 	 
	For and on behalf of 	 
	Virax Biolabs Limited	 
	 	 	 
	By:	/s/ Foster
    James Alexander Cunliffe	 
	Name:	Foster James Alexander
    Cunliffe	 
	Title:	Director	 

 

    11

     

    

 

	Selling Shareholders	 	 
	 	 	 
	/s/ Foster
    James Alexander Cunliffe 	 	/s/ Shaw Cameron
    Lee
	Foster James Alexander Cunliffe 	 	Shaw Cameron Lee
	 	 	 
	/s/ Ternouth Mark
    James	 	/s/ George Tomasz
    Evan
	Ternouth Mark James	 	George Tomasz Evan
	 	 	 
	For and on behalf of	 	For and on behalf of
	VIRALCLEAR RAPID TEST CORP.	 	Kasin Pte. Ltd.
	 	 	 
	/s/ Alexander Somjen		/s/
    Sebastian Kohler
	By:	Alexander Somjen 	 	By: 	Sebastian Kohler 
	Title: 	Director	 	Title: 	Director  
	 	 	 
	/s/ Shenk Jason
    Gerald	 	/s/
    Chaumet Sebastien
	Shenk Jason Gerald	 	Chaumet Sebastien
	 	 	 
	/s/ Foster Patrick
    Henry Cunliffe	 	/s/ Gordon Katherine
    Nahon
	Foster Patrick Henry Cunliffe	 	Gordon Katherine Nahon
	 	 	 
	/s/
    Feiss III George James	 	/s/
    Smayda Alex Lucas
	Feiss III George James	 	Smayda Alex Lucas
	 	 	 
	/s/ Liebe
    Paul Lawrence	 	/s/ Foster
    Fiona Elizabeth Cunliffe
	Liebe Paul Lawrence	 	Foster Fiona Elizabeth Cunliffe
	 	 	 
	/s/
    Thornton James Fitzgerald	 	/s/
    Foster Anne Rosemary Scott
	Thornton James Fitzgerald	 	Foster Anne Rosemary
    Scott 

 

    12

     

    

 

	/s/
    Parken Darold H	 	/s/
    Hausherr Rudiger Gisbert Paul
	Parken
                                            Darold H
	 
	Hausherr
                                            Rudiger Gisbert Paul

 

	/s/
    Monson Gary Lance	 	/s/
    Betsalel Steven Michael 
	Monson
                                            Gary Lance
	 	Betsalel
    Steven Michael

 

	/s/
    Newby Jay Eliot	 	/s/
    Youngman Kevin James
	Newby
    Jay Eliot	 	Youngman
    Kevin James

 

	/s/
    Johnston Rowan Kenley	 	/s/
    Brock Arthur Thomas
	Johnston
    Rowan Kenley	 	Brock
    Arthur Thomas

 

	/s/
    Friedrich Panning Heinz Hermann	 	/s/
    Sundher Ranjeet
	Friedrich
                                            Panning Heinz Hermann

    
	 	Sundher
                                            Ranjeet

                                                                                       

 

	/s/
    Gee Ian Denis	 	/s/
    Braun Gregory D L
	Gee
                                            Ian Denis
	 	Braun
                                            Gregory D L

 

	For
                                            and on behalf of

    Pacific
    Frontier Investments LLC
	For
                                            and on behalf of 

                                                                     STBS
                                            Consultants Limited

 

	/s/
    Mark Murrel	 	/s/
    Theodore Harrison
	By:
	Mark
                                            Murrel
	 	By:
	Theodore
                                            Harrison

                                                                                

	Title:
    	Director	 	Title:	Director

 

	For
                                            and on behalf of

                                                                                Seraph
                                            Holdings Ltd.
	For
                                            and on behalf of

                                                                                H&P
                                            Facilities Limited

 

	/s/
Marvin Yee 	 	/s/
                                            Neil Passmore
	By:	Marvin
                                            Yee 	 	By:	Neil
                                            Passmore
	Title:	Director	 	Title:	Director

 

    13

     

    

 

	For and on behalf of	For and on behalf of
	Dunster 22 Limited	Veritas Holdings LLC

 

	/s/ James Thornton	 	/s/ Christopher May
	By: 	James Thornton	 	By:	Christopher May
	Title: 	Director	 	Title:	Director

 

	
    For and on behalf of

    Sam Dimas Limited
	
    For and on behalf of

    Gralex Corporation

 

	/s/ Yati Merrin	 	/s/ Jinwei Ma
	By: 	Yati Merrin	 	By:	Jinwei Ma
	Title: 	Director	 	Title:	Director

 

	/s/ Michael Roukounakis	 	/s/ Rhee Lawrence Young
	Michael Roukounakis	 	Rhee Lawrence Young

 

	 	For and on behalf of

KOMODO HOLDINGS (ALBERTA) ULC

 

	/s/ Perrault Nikolas	 	/s/ Nikolas Perrault
	Perrault Nikolas	 	By: 	Nikolas Perrault
	 	 	Title: 	Director

 

    14

     

    

 

SCHEDULE
1 

 

Share
Exchange between HK Shares and Cayman Shares

 

	Name of Selling Shareholder	 	HK Shares

 held and

 to be transferred	 	 	% held in 
 HK
 Company	 	 	No. and class of Cayman

 Shares to be issued	 	 		 	% held in
 Cayman
 Company	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Foster James Alexander Cunliffe	 	 	37,592,784	 	 	 	36.68	%	 	 	3,515,508	*	 	Class B	 	 	36.68	%
	Shaw Cameron Lee	 	 	34,841,144	 	 	 	34.00	%	 	 	3,258,188	 	 	Class B	 	 	34.00	%
	Ternouth Mark James	 	 	636,800	 	 	 	0.62	%	 	 	59,551	 	 	Class B	 	 	0.62	%
	George Tomasz Evan	 	 	2,150,000	 	 	 	2.10	%	 	 	201,058	 	 	Class B	 	 	2.10	%
	VIRALCLEAR RAPID TEST CORP.	 	 	4,000,001	 	 	 	3.90	%	 	 	374,062	 	 	Class A	 	 	3.90	%
	Shenk Jason Gerald	 	 	7,625,120	 	 	 	7.44	%	 	 	713,067	 	 	Class A	 	 	7.44	%
	Chaumet Sebastien	 	 	4,687	 	 	 	0.00	%	 	 	438	 	 	Class A	 	 	0.00	%
	Kasin Pte. Ltd.	 	 	185,584	 	 	 	0.18	%	 	 	17,355	 	 	Class A	 	 	0.18	%
	Foster Patrick Henry Cunliffe	 	 	7,887,121	 	 	 	7.70	%	 	 	737,568	 	 	Class A	 	 	7.70	%
	Gordon Katherine Nahon	 	 	5,500	 	 	 	0.01	%	 	 	514	 	 	Class A	 	 	0.01	%
	Feiss III George James	 	 	35,616	 	 	 	0.03	%	 	 	3,331	 	 	Class A	 	 	0.03	%
	Smayda Alex Lucas	 	 	13,200	 	 	 	0.01	%	 	 	1,234	 	 	Class A	 	 	0.01	%
	Liebe Paul Lawrence	 	 	39,318	 	 	 	0.04	%	 	 	3,677	 	 	Class A	 	 	0.04	%
	Foster Fiona Elizabeth Cunliffe	 	 	689,299	 	 	 	0.67	%	 	 	64,460	 	 	Class A	 	 	0.67	%
	Thornton James Fitzgerald	 	 	352,000	 	 	 	0.34	%	 	 	32,917	 	 	Class A	 	 	0.34	%
	Foster Anne Rosemary Scott	 	 	275,000	 	 	 	0.27	%	 	 	25,717	 	 	Class A	 	 	0.27	%
	Parken Darold H	 	 	89,100	 	 	 	0.09	%	 	 	8,332	 	 	Class A	 	 	0.09	%
	Hausherr Rudiger Gisbert Paul	 	 	11,000	 	 	 	0.01	%	 	 	1,029	 	 	Class A	 	 	0.01	%
	Monson Gary Lance	 	 	176,000	 	 	 	0.17	%	 	 	16,459	 	 	Class A	 	 	0.17	%
	Betsalel Steven Michael	 	 	89,980	 	 	 	0.09	%	 	 	8,415	 	 	Class A	 	 	0.09	%
	Newby Jay Eliot	 	 	22,000	 	 	 	0.02	%	 	 	2,057	 	 	Class A	 	 	0.02	%
	Youngman Kevin James	 	 	103,169	 	 	 	0.10	%	 	 	9,648	 	 	Class A	 	 	0.10	%
	Johnston Rowan Kenley	 	 	181,534	 	 	 	0.18	%	 	 	16,976	 	 	Class A	 	 	0.18	%
	Brock Arthur Thomas	 	 	140,597	 	 	 	0.14	%	 	 	13,148	 	 	Class A	 	 	0.14	%
	Friedrich Panning Heinz Hermann	 	 	184,800	 	 	 	0.18	%	 	 	17,282	 	 	Class A	 	 	0.18	%
	Sundher Ranjeet	 	 	270,600	 	 	 	0.26	%	 	 	25,305	 	 	Class A	 	 	0.26	%
	Gee Ian Denis	 	 	86,233	 	 	 	0.08	%	 	 	8,064	 	 	Class A	 	 	0.08	%
	Pacific Frontier Investments LLC	 	 	52,617	 	 	 	0.05	%	 	 	4,921	 	 	Class A	 	 	0.05	%
	STBS Consultants Limited	 	 	132,589	 	 	 	0.13	%	 	 	12,399	 	 	Class A	 	 	0.13	%
	Seraph Holdings Ltd.	 	 	66,610	 	 	 	0.06	%	 	 	6,229	 	 	Class A	 	 	0.06	%
	H&P Facilities Limited	 	 	220,000	 	 	 	0.21	%	 	 	20,573	 	 	Class A	 	 	0.21	%
	Dunster 22 Limited	 	 	110,000	 	 	 	0.11	%	 	 	10,287	 	 	Class A	 	 	0.11	%
	Veritas Holdings LLC	 	 	165,000	 	 	 	0.16	%	 	 	15,430	 	 	Class A	 	 	0.16	%
	Braun Gregory D L	 	 	33,743	 	 	 	0.03	%	 	 	3,155	 	 	Class A	 	 	0.03	%
	Sam Dimas Limited	 	 	259,050	 	 	 	0.25	%	 	 	24,225	 	 	Class A	 	 	0.25	%
	Gralex Corporation	 	 	275,000	 	 	 	0.27	%	 	 	25,717	 	 	Class A	 	 	0.27	%
	Michael Roukounakis	 	 	22,000	 	 	 	0.02	%	 	 	2,057	 	 	Class A	 	 	0.02	%
	Rhee Lawrence Young	 	 	1,526,876	 	 	 	1.49	%	 	 	142,787	 	 	Class A	 	 	1.49	%
	Perrault Nikolas	 	 	1,526,876	 	 	 	1.49	%	 	 	142,787	 	 	Class A	 	 	1.49	%
	KOMODO HOLDINGS (ALBERTA) ULC	 	 	400,000	 	 	 	0.39	%	 	 	37,406	 	 	Class A	 	 	0.39	%
	TOTAL ISSUED SHARES HELD BY SELLING SHAREHOLDERS	 	 	102,478,548	 	 	 	 	 	 	 	2,549,028	 	 	Class A	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	7,034,306	**	 	Class B	 	 	 	 

 

		*	Note:
Foster James Alexander Cunliffe currently holds 1 Class B Share in Cayman Holdco, and accordingly his total shareholding after the completion
of this transaction will be 3,515,509 Class B Shares.

 

		**	Inclusive
of the existing 1 Class B Share held by Foster James Alexander Cunliffe prior to the date of this Agreement.

 

    15

     

    

 

SCHEDULE
2 

 

MEMORANDUM
AND ARTICLES OF ASSOCIATION OF CAYMAN HOLDCO 

 

    16

     

    

 

SCHEDULE
3 

 

GROUP
STRUCTURE CHART

 

 

 

 

17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]